October 13, 2017

If the tables, charts, or other content in this email version of the newsletter do not display properly, please check it out at our at our blog HERE

To subscribe to our bulletins and receive content whenever it is published, subscribe at our blog HERE

This week, we provide top-five ranked VE data for our Medical stocks. We take a look at our latest data on Twitter TWTR$ and provide a free download link for our stock report on the company.

VALUATION WATCH: Overvalued stocks now make up 61.01% of our stocks assigned a valuation and 26.54% of those equities are calculated to be overvalued by 20% or more. Fourteen sectors are calculated to be overvalued. Because overvaluation is now calculated to be above 60%, we have re-instituted our valuation watch.

ValuEngine Index Overview

Index	Week Open	Friday PM	Change	% Change	YTD
DJIA	22827.65	22887.92	60.27	0.26%	15.81%
NASDAQ	6586.73	6613.93	27.2	0.41%	22.86%
RUSSELL 2000	1507.91	1505.19	-2.72	-0.18%	10.91%
S&P 500	2550.62	2556.79	6.17	0.24%	14.20%

ValuEngine Market Overview

Summary of VE Stock Universe
Stocks Undervalued	38.99%
Stocks Overvalued	61.01%
Stocks Undervalued by 20%	18.44%
Stocks Overvalued by 20%	26.54%

ValuEngine Sector Overview

Sector	Change	MTD	YTD	Valuation	Last 12-MReturn	P/E Ratio
Aerospace	-0.41%	1.15%	16.10%	28.99% overvalued	35.00%	23.08
Computer and Technology	-0.08%	2.55%	27.12%	15.98% overvalued	22.39%	33.17
Industrial Products	0.22%	1.54%	14.59%	15.11% overvalued	26.21%	25.61
Utilities	0.02%	1.56%	23.82%	10.64% overvalued	17.61%	23.42
Multi-Sector Conglomerates	0.14%	0.65%	12.55%	10.30% overvalued	14.16%	20.51
Auto-Tires-Trucks	-0.40%	2.16%	28.26%	10.14% overvalued	34.13%	14.99
Finance	-0.17%	1.28%	11.17%	9.88% overvalued	17.45%	18.85
Construction	-0.33%	0.44%	21.47%	9.54% overvalued	27.19%	22.54
Consumer Discretionary	-0.55%	0.41%	14.65%	7.07% overvalued	18.29%	25.26
Business Services	0.20%	1.40%	10.61%	6.18% overvalued	9.64%	26.64
Transportation	0.12%	0.60%	17.98%	5.37% overvalued	22.52%	23.22
Consumer Staples	-0.01%	1.34%	7.16%	4.79% overvalued	8.36%	26.08
Basic Materials	0.18%	1.91%	17.32%	3.53% overvalued	16.76%	28.19
Medical	-0.65%	0.05%	22.60%	3.44% overvalued	12.36%	29.01
Retail-Wholesale	-0.94%	-1.63%	1.44%	4.71% undervalued	4.03%	23.29
Oils-Energy	-0.70%	-1.21%	2.34%	12.20% undervalued	-5.48%	28.65

Sector Talk--Medical

Below, we present the latest data on Medical stocks from our Professional Stock Analysis Service. Top- five lists are provided for each category. We applied some basic liquidity criteria--share price greater than $3 and average daily volume in excess of 100k shares.

Top-Five Medical Stocks--Short-Term Forecast Returns

Ticker	Name	Mkt Price	Valuation (%)	Last 12-M Return (%)
GILD	GILEAD SCIENCES	81.3	12.26%	11.32%
AZN	ASTRAZENECA PLC	34.53	9.62%	12.11%
ANTM	ANTHEM INC	189.74	12.60%	57.00%
PDLI	PDL BIOPHARMA	3.45	-40.70%	6.48%
MYL	MYLAN NV	37.76	-20.34%	1.86%

Top-Five Medical Stocks--Momentum

Ticker	Name	Mkt Price	Valuation (%)	Last 12-M Return (%)
CALA	CALITHERA BIOSC	17.6	N/A	494.59%
CBAY	CYMABAY THERAPT	8.67	63.17%	407.02%
IMMU	IMMUNOMEDICS	11.59	72.38%	363.60%
ESPR	ESPERION THERAP	55.54	167.71%	350.81%
AVEO	AVEO PHARMACEUT	3.68	74.39%	343.37%

Top-Five Medical Stocks--Composite Score

Ticker	Name	Mkt Price	Valuation (%)	Last 12-M Return (%)
INVA	INNOVIVA INC	13.9	-33.86%	38.58%
MYL	MYLAN NV	37.76	-20.34%	1.86%
ANTM	ANTHEM INC	189.74	12.60%	57.00%
AET	AETNA INC-NEW	154.49	6.56%	39.97%
SNY	SANOFI-AVENTIS	49.74	6.22%	31.07%

Top-Five Medical Stocks--Most Overvalued

Ticker	Name	Mkt Price	Valuation (%)	Last 12-M Return (%)
CYH	COMMNTY HLTH SY	6.01	300.00%	-42.54%
VIVE	VIVEVE MEDICAL	5.49	300.00%	-18.79%
CLSN	CELSION CORP	5.15	300.00%	-68.30%
LJPC	LA JOLLA PHARMA	35.08	218.69%	70.29%
CASI	CASI PHARMACEUT	3.64	199.06%	134.84%

Free Download for Readers

As a bonus to our Free Weekly Newsletter subscribers,
we are offering a FREE DOWNLOAD of one of our Stock Reports

Twitter (TWTR) is a public, real-time, global platform where any user can create a Tweet and any user can follow other users. The platform is unique in its simplicity: Tweets are limited to 140 characters of text. This constraint makes it easy for anyone to quickly create, distribute and discover content that is consistent across our platform and optimized for mobile devices. As a result, Tweets drive a high velocity of information exchange that makes Twitter uniquely live.

VALUENGINE RECOMMENDATION: ValuEngine continues its SELL recommendation on TWITTER INC for 2017-10-12. Based on the information we have gathered and our resulting research, we feel that TWITTER INC has the probability to UNDERPERFORM average market performance for the next year. The company exhibits UNATTRACTIVE Sharpe Ratio and Price Sales Ratio.

You can download a free copy of detailed report on Twitter (TWTR) from the link below.

Read our Complete Rating and Forecast Report HERE.

ValuEngine Forecast
	Target Price*	Expected Return
1-Month	18.35	-0.52%
3-Month	17.91	-2.94%
6-Month	17.36	-5.90%
1-Year	17.29	-6.29%
2-Year	14.11	-23.53%
3-Year	12.50	-32.26%

Valuation & Rankings
Valuation	28.63% undervalued	Valuation Rank(?)	87
1-M Forecast Return	-0.52%	1-M Forecast Return Rank	17
12-M Return	2.22%	Momentum Rank(?)	39
Sharpe Ratio	-0.47	Sharpe Ratio Rank(?)	18
5-Y Avg Annual Return	-23.53%	5-Y Avg Annual Rtn Rank	20
Volatility	50.47%	Volatility Rank(?)	33
Expected EPS Growth	107.69%	EPS Growth Rank(?)	86
Market Cap (billions)	11.71	Size Rank	90
Trailing P/E Ratio	n/a	Trailing P/E Rank(?)	28
Forward P/E Ratio	1,845.00	Forward P/E Ratio Rank	1
PEG Ratio	1.32	PEG Ratio Rank	37
Price/Sales	4.77	Price/Sales Rank(?)	23
Market/Book	3.37	Market/Book Rank(?)	38
Beta	1.02	Beta Rank	39
Alpha	-0.46	Alpha Rank	12

ValuEngine.com is an Independent Research Provider (IRP), producing buy/hold/sell recommendations, target price, and valuations on over 5,000 US and Canadian equities every trading day.
Contact ValuEngine at (800) 381-5576 or support@valuengine.com
Visit www.ValuEngine.com for more information

ValuEngine Capital Management LLC is a Registered Investment Advisory (RIA) firm that trades client accounts using ValuEngine's award-winning stock research.
Contact ValuEngine Capital at info@valuenginecapital.com
Visit www.ValuEngineCapital.com for more information

If you no longer wish to receive this free newsletter, CLICK HERE to unsubscribe

An archive of this weekly newsletter is available here.